Technical – Achieve Life Sciences

Search for:

Home/Technical

Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research
April 14th, 2021
Achieve Life Sciences Announces Presentation of Data on Smoker and E-Cigarette User Attitudes and Perceptions on Quitting at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting
February 24th, 2021
Achieve Announces Publication of the RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) in Addiction
March 25th, 2021

A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)
April 14th, 2021
Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research
April 14th, 2021
Cytisinicline – the solution to stop smoking?
April 13th, 2021

22722 29th Dr SE, Suite 100
Bothell, WA 98021

1040 W Georgia Street, Suite 1030
Vancouver, BC V6E 4H1